nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—ovarian follicle—polycystic ovary syndrome	0.129	0.315	CbGeAlD
Lornoxicam—CYP2C9—urine—polycystic ovary syndrome	0.0616	0.151	CbGeAlD
Lornoxicam—PTGS2—embryo—polycystic ovary syndrome	0.0174	0.0427	CbGeAlD
Lornoxicam—PTGS2—adrenal cortex—polycystic ovary syndrome	0.0142	0.035	CbGeAlD
Lornoxicam—PTGS1—endometrium—polycystic ovary syndrome	0.0133	0.0327	CbGeAlD
Lornoxicam—PTGS2—endometrium—polycystic ovary syndrome	0.0127	0.0312	CbGeAlD
Lornoxicam—PTGS1—uterus—polycystic ovary syndrome	0.0123	0.0301	CbGeAlD
Lornoxicam—PTGS1—pituitary gland—polycystic ovary syndrome	0.012	0.0296	CbGeAlD
Lornoxicam—PTGS1—adipose tissue—polycystic ovary syndrome	0.012	0.0294	CbGeAlD
Lornoxicam—PTGS2—uterus—polycystic ovary syndrome	0.0117	0.0288	CbGeAlD
Lornoxicam—PTGS2—pituitary gland—polycystic ovary syndrome	0.0115	0.0282	CbGeAlD
Lornoxicam—PTGS2—adipose tissue—polycystic ovary syndrome	0.0115	0.0281	CbGeAlD
Lornoxicam—PTGS1—adrenal gland—polycystic ovary syndrome	0.0108	0.0264	CbGeAlD
Lornoxicam—PTGS2—adrenal gland—polycystic ovary syndrome	0.0103	0.0252	CbGeAlD
Lornoxicam—CYP2C9—endocrine gland—polycystic ovary syndrome	0.0102	0.0251	CbGeAlD
Lornoxicam—PTGS1—female gonad—polycystic ovary syndrome	0.01	0.0246	CbGeAlD
Lornoxicam—PTGS1—vagina—polycystic ovary syndrome	0.00997	0.0245	CbGeAlD
Lornoxicam—PTGS2—female gonad—polycystic ovary syndrome	0.00958	0.0235	CbGeAlD
Lornoxicam—PTGS2—vagina—polycystic ovary syndrome	0.00953	0.0234	CbGeAlD
Lornoxicam—PTGS1—endocrine gland—polycystic ovary syndrome	0.00933	0.0229	CbGeAlD
Lornoxicam—PTGS2—endocrine gland—polycystic ovary syndrome	0.00891	0.0219	CbGeAlD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00341	0.00576	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00341	0.00575	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00333	0.00561	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00332	0.0056	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00328	0.00554	CbGpPWpGaD
Lornoxicam—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00316	0.00534	CbGpPWpGaD
Lornoxicam—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00311	0.00525	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.003	0.00507	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00296	0.005	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00287	0.00485	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00286	0.00482	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00281	0.00475	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00279	0.00471	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00278	0.00469	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00276	0.00465	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00276	0.00465	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00275	0.00464	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00264	0.00445	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00261	0.00441	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00246	0.00415	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00244	0.00411	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00239	0.00402	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00235	0.00397	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00233	0.00392	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00229	0.00386	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00226	0.00382	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00221	0.00373	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00221	0.00373	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00219	0.00369	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00218	0.00368	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00217	0.00366	CbGpPWpGaD
Lornoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00212	0.00358	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00209	0.00353	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00208	0.00352	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00208	0.00352	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00206	0.00348	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00205	0.00346	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00199	0.00336	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00186	0.00314	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00185	0.00312	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00185	0.00312	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00181	0.00305	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00179	0.00302	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00178	0.00301	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00176	0.00297	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00176	0.00296	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00175	0.00295	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.0017	0.00287	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00166	0.00279	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00165	0.00279	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00165	0.00279	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00165	0.00279	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00158	0.00266	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00157	0.00264	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00156	0.00263	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00147	0.00248	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00146	0.00246	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00146	0.00246	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00144	0.00244	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00144	0.00243	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00139	0.00234	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00139	0.00234	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.00136	0.00229	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00135	0.00228	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00134	0.00227	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00133	0.00224	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00131	0.00222	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00129	0.00218	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.00129	0.00217	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00129	0.00217	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00128	0.00217	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00128	0.00215	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00125	0.00212	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00122	0.00207	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.00122	0.00205	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.0012	0.00203	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.0012	0.00203	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.0012	0.00202	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00119	0.002	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.00117	0.00198	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00117	0.00198	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00116	0.00196	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0011	0.00185	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0011	0.00185	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.0011	0.00185	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00109	0.00184	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.00109	0.00184	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00108	0.00182	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00107	0.0018	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00107	0.0018	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00102	0.00172	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000996	0.00168	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000972	0.00164	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000952	0.00161	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00095	0.0016	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000945	0.00159	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000939	0.00158	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000932	0.00157	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000932	0.00157	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000928	0.00157	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000928	0.00157	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00092	0.00155	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000918	0.00155	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000892	0.00151	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000879	0.00148	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00087	0.00147	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000867	0.00146	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000847	0.00143	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00083	0.0014	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000808	0.00136	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000791	0.00133	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000778	0.00131	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000767	0.00129	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000764	0.00129	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000757	0.00128	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00075	0.00127	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000737	0.00124	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000737	0.00124	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000737	0.00124	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000708	0.0012	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000706	0.00119	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000703	0.00119	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000697	0.00118	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000695	0.00117	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000675	0.00114	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000667	0.00113	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000644	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000642	0.00108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000629	0.00106	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000627	0.00106	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000627	0.00106	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000617	0.00104	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000617	0.00104	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000617	0.00104	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000609	0.00103	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000598	0.00101	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000594	0.001	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000591	0.000997	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000585	0.000988	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000574	0.000968	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000572	0.000965	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000561	0.000946	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00056	0.000946	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000558	0.000942	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000552	0.000931	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000545	0.00092	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000533	0.000899	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000524	0.000883	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000516	0.000871	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000507	0.000856	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000499	0.000842	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000498	0.00084	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000497	0.000838	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000489	0.000826	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000488	0.000823	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000488	0.000823	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000475	0.000802	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000475	0.000801	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000469	0.000792	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000469	0.000792	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000462	0.000779	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.00046	0.000776	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000454	0.000766	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.00045	0.00076	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000445	0.000751	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000444	0.000748	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000433	0.000731	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000426	0.000719	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000424	0.000715	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000423	0.000714	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000421	0.00071	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000418	0.000705	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000415	0.0007	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.00041	0.000692	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000409	0.00069	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000404	0.000682	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000397	0.000671	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000391	0.00066	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000388	0.000654	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000377	0.000636	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000377	0.000636	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000371	0.000626	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.00037	0.000624	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000366	0.000617	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000365	0.000616	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000352	0.000594	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000339	0.000571	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000338	0.000571	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000336	0.000567	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000334	0.000564	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000332	0.00056	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.00033	0.000556	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000329	0.000556	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000318	0.000536	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000316	0.000532	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000314	0.000531	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000312	0.000527	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000311	0.000524	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000311	0.000524	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.00031	0.000522	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000298	0.000502	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000295	0.000497	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000287	0.000484	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.00028	0.000473	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000276	0.000466	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000271	0.000458	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000269	0.000453	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000263	0.000444	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000261	0.000441	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.00025	0.000421	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.00025	0.000421	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.00025	0.000421	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000246	0.000415	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000245	0.000413	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000242	0.000408	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000233	0.000393	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000233	0.000393	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000224	0.000378	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000223	0.000376	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000221	0.000373	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000221	0.000372	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00022	0.000371	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000219	0.00037	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.00021	0.000354	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.000209	0.000353	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000209	0.000353	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000206	0.000347	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000198	0.000334	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000189	0.000318	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000186	0.000314	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.000185	0.000312	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.000185	0.000312	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.000183	0.000309	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000178	0.0003	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—INS—polycystic ovary syndrome	0.000175	0.000296	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000173	0.000292	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.00017	0.000286	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000163	0.000275	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000161	0.000272	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	0.00015	0.000253	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—POMC—polycystic ovary syndrome	0.000148	0.000249	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—INS—polycystic ovary syndrome	0.000147	0.000248	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	0.000145	0.000245	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	0.000138	0.000234	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000131	0.000221	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	0.000122	0.000206	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	9.92e-05	0.000167	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	9.78e-05	0.000165	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—INS—polycystic ovary syndrome	9.73e-05	0.000164	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—polycystic ovary syndrome	7.67e-05	0.000129	CbGpPWpGaD
